InformAI

InformAI, located in Houston’s Texas Medical Center, specializes in creating AI-driven enterprise software solutions aimed at enhancing healthcare quality, safety, and efficiency. The company’s product lineup includes RadOncAI, SinusAI, and TransplantAI, each designed to meet specific clinical needs. RadOncAI is engineered to optimize radiation therapy plans, focusing on targeting tumors while protecting adjacent healthy tissues. SinusAI enhances CT imaging diagnostics through AI-enabled precision, improving outcomes in sinus-related treatments. TransplantAI serves as a donor-recipient informatics platform that facilitates AI-powered transplant decisions at the point of care. InformAI’s products are known for being enterprise-grade, seamless, and scalable, catering to the demanding environments of elite medical institutions. The company has also established strong partnerships with these institutions and deploys its solutions through direct channel partners. Additionally, InformAI was awarded a $2.2 million Fast-Track to Phase 2 award from the National Institute of Health for the development and commercialization of TransplantAI, underscoring its commitment to advancing healthcare through innovative technologies.